APOE and Alzheimer disease: APOE4 individuals with late onset AD have higher levels of brain amyloid (parenchymal and CAA) [131–133]; APOE2 individuals have lower levels of parenchymal Aβ, although, paradoxically, a higher incidence of CAA [134–136].